Stay updated with breaking news from Roberta Hauser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analyses of pivotal study data of Dysport® reveal a large proportion of study patients did not require retreatment for at least 12 weeks This new analysis...
- IPX203 demonstrated statistically significant improvement in daily “Good On” time compared to optimized IR CD/LD, with fewer daily doses ...
/PRNewswire/ -- Vial welcomes Robert A. Hauser, MD, MBA, as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Hauser is the...
GuruFocus Article or News written by Business Wire and the topic is about:
Phase 1/1b '101' study terminated early; demonstrated favorable safety, tolerability, and pharmacokinetic profile in single doses up to 325 mg and...